SEPTOCAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Septocaine, and what generic alternatives are available?
Septocaine is a drug marketed by Deproco and is included in one NDA.
The generic ingredient in SEPTOCAINE is articaine hydrochloride; epinephrine bitartrate. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the articaine hydrochloride; epinephrine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SEPTOCAINE?
- What are the global sales for SEPTOCAINE?
- What is Average Wholesale Price for SEPTOCAINE?
Summary for SEPTOCAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 61 |
| Clinical Trials: | 6 |
| Drug Prices: | Drug price information for SEPTOCAINE |
| DailyMed Link: | SEPTOCAINE at DailyMed |
Recent Clinical Trials for SEPTOCAINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alfarabi Colleges | N/A |
| Virginia Commonwealth University | Phase 2 |
| University of Michigan | Phase 4 |
Pharmacology for SEPTOCAINE
| Drug Class | Amide Local Anesthetic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for SEPTOCAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deproco | SEPTOCAINE | articaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 020971-002 | Mar 30, 2006 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Deproco | SEPTOCAINE | articaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 020971-001 | Apr 3, 2000 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
